Financials

News Ideas Discussions Technicals Forecast Seasonals

BIOPOR fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The firm specializes in coagulation, immunodeficiency, diabetes, peptide hormones, and kidney diseases. Its portfolio consists of NGAL Test, NGAL ELISA kits, MBL ELISA kits, and Antibody Shop. The company was founded on November 22, 1917 and is headquartered in Hellerup, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

BIOPOR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company